{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T22:55:49Z","timestamp":1770332149089,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":196,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.jhep.2012.09.015","type":"journal-article","created":{"date-parts":[[2012,9,27]],"date-time":"2012-09-27T18:21:42Z","timestamp":1348770102000},"page":"195-198","source":"Crossref","is-referenced-by-count":6,"title":["Fondaparinux (Arixtra\u2217) hepatotoxicity in a 6 year-old child"],"prefix":"10.1016","volume":"58","author":[{"given":"Lupe","family":"Orostegui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Medejel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Kone-Paut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Dreyfus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Benhamou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2012.09.015_b0005","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2147\/vhrm.2006.2.4.365","article-title":"Review of fondaparinux sodium injection for the prevention of venous thromboembolism in patients undergoing surgery","volume":"2","author":"Bergqvist","year":"2006","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.jhep.2012.09.015_b0010","doi-asserted-by":"crossref","first-page":"867","DOI":"10.7326\/0003-4819-140-11-200406010-00007","article-title":"Matisse Investigators. Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial","volume":"140","author":"B\u00fcller","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2012.09.015_b0015","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1161\/CIRCULATIONAHA.108.789479","volume":"118","author":"Mehta","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jhep.2012.09.015_b0020","unstructured":"Arixtra (fondaparinux sodium) injection. Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) \u2013 August 2009. http:\/\/www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/ucm182229.htm [accessed 16.05.10]."},{"key":"10.1016\/j.jhep.2012.09.015_b0025","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00003088-200241002-00003","article-title":"Fondaparinux sodium is not metabolised in mammalian liver fractions and does not inhibit cytochrome P450-mediated metabolism of concomitant drugs","volume":"41","author":"Lieu","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jhep.2012.09.015_b0030","doi-asserted-by":"crossref","first-page":"638","DOI":"10.2146\/ajhp080311","article-title":"Probable enoxaparin-induced hepatotoxicity","volume":"66","author":"Baker","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jhep.2012.09.015_b0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000469325","article-title":"Evaluation of heparin toxicity in the isolated and perfused rat liver","volume":"35","author":"Capuano","year":"1986","journal-title":"Enzyme"},{"key":"10.1016\/j.jhep.2012.09.015_b0040","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1592\/phco.21.1.108.34436","article-title":"Elevation of hepatic transaminases after enoxaparin use: case report and review of unfractionated and low-molecular-weight heparininduced hepatotoxicity","volume":"21","author":"Carlson","year":"2001","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jhep.2012.09.015_b0045","first-page":"137","article-title":"Heparin-induced transaminase elevations: a prospective study","volume":"31","author":"Guevara","year":"1993","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1016\/j.jhep.2012.09.015_b0050","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1177\/00912700122010465","article-title":"Low molecular weight heparin-induced liver toxicity","volume":"41","author":"Hui","year":"2001","journal-title":"J Clin Pharmacol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827812007465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827812007465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T03:57:13Z","timestamp":1562212633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827812007465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0168827812007465"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2012.09.015","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}